Back
Western Asset High Income Fund II Vs. Novartis AG Industry Stock Comparison
Sell
31
HIX
Western Asset High Income Fund II
Last Price:
$4.23
Seasonality Move:
0.4%
Buy
62
NVSEF
Novartis AG
Last Price:
$109.00
Seasonality Move:
5.79%
Sell
31
Western Asset High Income Fund II (HIX)
is a Sell
Is Western Asset High Income Fund II a Buy, Sell or Hold?
-
The current Western Asset High Income Fund II [HIX] share price is $4.26. The Score for HIX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
HIX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $109.00. The Score for NVSEF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HIX Stock Price Chart
What is Western Asset High Income Fund II's stock price today?
-
The Western Asset High Income Fund II share price today is $4.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIX is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.00The current trend is moderately bearish and NVSEF is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 33.26 | Sell |
| Chaikin Money Flow: | -194183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.33 - 4.41) | Sell |
| Bollinger Bands (100): | (4.28 - 4.46) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.7 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | 5487 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.67 - 112.23) | Buy |
| Bollinger Bands (100): | (98.63 - 109.37) | Buy |
HIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.35 | Sell |
| 20-day SMA: | 4.37 | Sell |
| 50-day SMA: | 4.31 | Sell |
| 200-day SMA: | 4.4 | Sell |
| 8-day EMA: | 4.33 | Sell |
| 20-day EMA: | 4.35 | Sell |
| 50-day EMA: | 4.35 | Sell |
| 200-day EMA: | 4.4 | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.29 | Sell |
| 20-day SMA: | 109.25 | Sell |
| 50-day SMA: | 103.73 | Buy |
| 200-day SMA: | 106.3 | Buy |
| 8-day EMA: | 112.15 | Sell |
| 20-day EMA: | 109.66 | Sell |
| 50-day EMA: | 106.19 | Buy |
| 200-day EMA: | 104.21 | Buy |
Western Asset High Income Fund II Earnings Growth & HIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Western Asset High Income Fund II Technical Analysis
| Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||